Refractory facial cutaneous B-cell pseudolymphoma successfully treated with dupilumab

JAAD Case Rep. 2024 Feb 18:46:95-99. doi: 10.1016/j.jdcr.2024.02.007. eCollection 2024 Apr.
No abstract available

Keywords: African American; B-cell pseudolymphoma; Type V skin; dupilumab; therapy.

Publication types

  • Case Reports